BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists. 2021

Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
School of Pharmacy, Fudan University, Shanghai 201203, China.

Relaxin family peptide receptors (RXFPs) are the potential therapeutic targets for neurological, cardiovascular, and metabolic indications. Among them, RXFP3 and RXFP4 (formerly known as GPR100 or GPCR142) are homologous class A G protein-coupled receptors with short N-terminal domain. Ligands of RXFP3 or RXFP4 are only limited to endogenous peptides and their analogues, and no natural product or synthetic agonists have been reported to date except for a scaffold of indole-containing derivatives as dual agonists of RXFP3 and RXFP4. In this study, a new scaffold of tricyclic derivatives represented by compound 7a was disclosed as a selective RXFP4 agonist after a high-throughput screening campaign against a diverse library of 52,000 synthetic and natural compounds. Two rounds of structural modification around this scaffold were performed focusing on three parts: 2-chlorophenyl group, 4-hydroxylphenyl group and its skeleton including cyclohexane-1,3-dione and 1,2,4-triazole group. Compound 14b with a new skeleton of 7,9-dihydro-4H-thiopyrano[3,4-d][1,2,4]triazolo[1,5-a]pyrimidin-8(5H)-one was thus obtained. The enantiomers of 7a and 14b were also resolved with their 9-(S)-conformer favoring RXFP4 agonism. Compared with 7a, compound 9-(S)-14b exhibited 2.3-fold higher efficacy and better selectivity for RXFP4 (selective ratio of RXFP4 vs. RXFP3 for 9-(S)-14b and 7a were 26.9 and 13.9, respectively).

UI MeSH Term Description Entries
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D003512 Cyclohexanones Cyclohexane ring substituted by one or more ketones in any position.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D018000 Receptors, Peptide Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells. Peptide Hormone Receptors,Peptide Receptors,Peptide Hormone Receptor,Peptide Receptor,Receptors, Peptide Hormones,Receptors, Peptides,Hormone Receptor, Peptide,Hormone Receptors, Peptide,Hormones Receptors, Peptide,Peptide Hormones Receptors,Peptides Receptors,Receptor, Peptide,Receptor, Peptide Hormone,Receptors, Peptide Hormone

Related Publications

Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT(4) receptor agonists.
May 2005, Bioorganic & medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Novel 4-thiazolidinone derivatives as agonists of benzodiazepine receptors: Design, synthesis and pharmacological evaluation.
January 2017, EXCLI journal,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists.
June 2017, Bioorganic & medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists.
April 2022, Molecular diversity,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists.
January 2017, Bioorganic & medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT(4) receptor agonists.
November 1999, European journal of medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
May 2010, Bioorganic & medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Synthesis and pharmacological properties of benzamide derivatives as selective serotonin 4 receptor agonists.
May 2004, Bioorganic & medicinal chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators.
December 2020, Bioorganic chemistry,
Lin Lin, and Guangyao Lin, and Qingtong Zhou, and Ross A D Bathgate, and Grace Qun Gong, and Dehua Yang, and Qing Liu, and Ming-Wei Wang
Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
November 2014, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!